Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB37 antisense RNA 1 (RAB37-AS1) is an antisense long non-coding RNA gene located on chromosome 17[7]. It is transcribed from the opposite DNA strand of the protein-coding RAB37 gene and is classified in the Sequence Ontology as “antisense_lncRNA_gene.” Antisense lncRNAs commonly modulate expression of their sense gene counterparts at the levels of transcription, mRNA stability, or chromatin structure, but the specific regulatory or biological function of RAB37-AS1 has not been characterized in published literature[6][7][3]. There is no evidence that RAB37-AS1 serves as a therapeutic target, or that it interacts with specific drugs, functions as a biomarker, or is linked to clinical safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB37 antisense RNA 1 (RAB37-AS1).